Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Biochem Biophys Res Commun ; 306(3): 650-9, 2003 Jul 04.
Article in English | MEDLINE | ID: mdl-12810068

ABSTRACT

Telomerase is active in about 90% of cancers and contributes to the immortality of cancer cells by maintaining the lengths of the ends of chromosomes. Undifferentiated embryonic human teratocarcinoma (HT) cells were found to express high levels of hTERT, the catalytic subunit of telomerase, and the hTERT promoter was unmethylated in these cells. Retinoic acid (RA)-induced differentiation led to hTERT gene silencing and increased methylation of the hTERT promoter. Treatment with trichostatin A, a histone deacetylase inhibitor, resulted in hTERT reactivation only in very early differentiating HT cells. After methylation patterns had been established within the hTERT promoter region in late differentiating cells, 5-azacytidine, a common demethylating agent, activated the hTERT gene but trichostatin A had no effect on hTERT transcription. These studies suggest that histone deacetylation is involved in early hTERT gene down-regulation and that DNA methylation may maintain silencing of the hTERT gene in these cells.


Subject(s)
Gene Expression Regulation, Enzymologic , Telomerase/metabolism , Teratocarcinoma/enzymology , Antineoplastic Agents/metabolism , Azacitidine/metabolism , Catalytic Domain , Cell Differentiation , DNA (Cytosine-5-)-Methyltransferases/metabolism , DNA-Binding Proteins , Enzyme Inhibitors/metabolism , Humans , Hydroxamic Acids/metabolism , Methylation , Promoter Regions, Genetic , Telomerase/genetics , Teratocarcinoma/genetics , Teratocarcinoma/pathology , Tretinoin/metabolism , Tumor Cells, Cultured
SELECTION OF CITATIONS
SEARCH DETAIL
...